Shukra Pharmaceuticals Rights Issue 2023 vs Vaxfab Enterprises Rights Issue 2023

Comparision between Shukra Pharmaceuticals Rights Issue 2023 and Vaxfab Enterprises Rights Issue 2023.

Rights Issue details

Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Shukra Pharmaceuticals Rights Issue 2023 and Vaxfab Enterprises Rights Issue 2023. Shukra Pharmaceuticals Rights Issue 2023 is listed on BSE while Vaxfab Enterprises Rights Issue 2023 is listed on BSE.

	Shukra Pharmaceuticals Limited	Vaxfab Enterprises Limited
Logo
Listing At	BSE	BSE
Terms of Payment	Rs. 5 per Rights Equity Share to be paid on Application and balance to be paid in three calls as determined.	The aggregate amount of Rs. 18 is to be payable at the time of Application.
Entitlement	6 Equity Shares for every 1 Fully Paid Equity Share held	6 RIGHTS EQUITY SHARES FOR EVERY 1 FULLY PAID-UP EQUITY SHARES
Application Form	Application Form	Application Form
Letter of Offer	Letter of Offer	Letter of Offer
Registrar	Purva Sharegistry India Pvt Ltd	Cameo Corporate Services Limited
Lead Managers

Rights Issue Size and Price

The issue size of Shukra Pharmaceuticals Rights Issue 2023 rights issue is ₹18.79 Crores, whereas Vaxfab Enterprises Rights Issue 2023 rights issue size is ₹12.96 Crores.

	Shukra Pharmaceuticals Limited	Vaxfab Enterprises Limited
Issue Size	93,94,050 shares	72,00,000 shares
Issue Size (Amount)	₹18.79 Crores	₹12.96 Crores
Issue Price	₹20 per share	₹18 per share
Face Value	₹10 per share	₹10 per share

Rights Issue Timetable

Find all the important dates related to the rights issue. The record date of Shukra Pharmaceuticals Rights Issue 2023 is Feb 02, 2023 while record date of Vaxfab Enterprises Rights Issue 2023 is Jan 03, 2023.

	Shukra Pharmaceuticals Limited	Vaxfab Enterprises Limited
Record Date	Feb 02, 2023	Jan 03, 2023
Credit of Rights Entitlements	Feb 13, 2023	Jan 13, 2023
Bid/Offer Opens On	Feb 15, 2023	Jan 18, 2023
Renunciation of Rights Entitlements	Feb 23, 2023	Feb 06, 2023
Bid/Offer Closes On	Feb 28, 2023	Feb 10, 2023
Deemed Date of Allotment	Mar 08, 2023	Feb 09, 2023
Credit Date	Mar 14, 2023	Feb 13, 2023
Listing Date	Mar 15, 2023	Feb 16, 2023

Financials details

Comparison of Shukra Pharmaceuticals Rights Issue 2023 and Vaxfab Enterprises Rights Issue 2023 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.

Shukra Pharmaceuticals Limited

Vaxfab Enterprises Limited

Financial

Shukra Pharmaceuticals Limited Financial Information (Consolidated)
Period Ended	Total Assets	Total Revenue	Profit After Tax	Net Worth
31-Mar-21	35.61	11.55	0.19	15.60
31-Mar-22	35.11	20.57	0.75	16.35
Amount in ₹ Crore

Vaxfab Enterprises Limited Financial Information (Consolidated)
Period Ended	Total Assets	Total Revenue	Profit After Tax	Net Worth	Total Borrowing
31-Mar-21	3.21	1.2	-0.01	3.12	0.07
31-Mar-22	3.15	0.37	0	3.12	0.02
Amount in ₹ Crore

Compare with others

Shukra Pharmaceuticals Limited	Vaxfab Enterprises Limited
Bright Solar Rights Issue 2023	Parvati Sweetners and Power Rights Issue 2023
Parvati Sweetners and Power Rights Issue 2023	Shree Ganesh Remedies Rights Issue 2023
Shree Ganesh Remedies Rights Issue 2023	Markolines Pavement Technologies Rights Issue 2023
Markolines Pavement Technologies Rights Issue 2023	Hazoor Multi Projects Rights Issue 2023
Hazoor Multi Projects Rights Issue 2023	Shukra Pharmaceuticals Rights Issue 2023
Vaxfab Enterprises Rights Issue 2023	Aarti Surfactants Rights Issue 2023
Aarti Surfactants Rights Issue 2023	Pacific Industries Rights Issue 2023
Pacific Industries Rights Issue 2023	Jet Freight Logistics Rights Issue 2023
Jet Freight Logistics Rights Issue 2023	Family Care Hospitals Rights Issue 2022
Family Care Hospitals Rights Issue 2022	AKG EXIM Rights Issue 2022

Comments

Add a public comment...